178 related articles for article (PubMed ID: 32830899)
21. Comparison of post-contrast 3D-T
Jeevanandham B; Kalyanpur T; Gupta P; Cherian M
Br J Radiol; 2017 Jun; 90(1074):20160834. PubMed ID: 28375660
[TBL] [Abstract][Full Text] [Related]
22. Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement.
Bhargava P; Wicken C; Smith MD; Strowd RE; Cortese I; Reich DS; Calabresi PA; Mowry EM
Mult Scler Relat Disord; 2019 May; 30():136-140. PubMed ID: 30771580
[TBL] [Abstract][Full Text] [Related]
23. Leptomeningeal enhancement in multiple sclerosis and other neurological diseases: A systematic review and Meta-Analysis.
Ineichen BV; Tsagkas C; Absinta M; Reich DS
Neuroimage Clin; 2022; 33():102939. PubMed ID: 35026625
[TBL] [Abstract][Full Text] [Related]
24. Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review.
Zurawski J; Lassmann H; Bakshi R
JAMA Neurol; 2017 Jan; 74(1):100-109. PubMed ID: 27893883
[TBL] [Abstract][Full Text] [Related]
25. Investigation of leptomeningeal enhancement in MS: a postcontrast FLAIR MRI study.
Eisele P; Griebe M; Szabo K; Wolf ME; Alonso A; Engelhardt B; Hennerici MG; Gass A
Neurology; 2015 Feb; 84(8):770-5. PubMed ID: 25616480
[TBL] [Abstract][Full Text] [Related]
26. Contrast-enhanced fat-suppressed FLAIR for the characterization of leptomeningeal inflammation in optic neuritis.
Pino-Lopez L; Wenz H; Böhme J; Maros M; Schlichtenbrede F; Groden C; Förster A
Mult Scler; 2019 May; 25(6):792-800. PubMed ID: 29683029
[TBL] [Abstract][Full Text] [Related]
27. Association of retinal atrophy with cortical lesions and leptomeningeal enhancement in multiple sclerosis on 7T MRI.
Mizell R; Chen H; Lambe J; Saidha S; Harrison DM
Mult Scler; 2022 Mar; 28(3):393-405. PubMed ID: 34125629
[TBL] [Abstract][Full Text] [Related]
28. Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images.
Li L; Liu W; Cai Q; Liu Y; Hu W; Zuo Z; Ma Q; He S; Jin K
Front Immunol; 2023; 14():1152235. PubMed ID: 37409120
[TBL] [Abstract][Full Text] [Related]
29. T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
Thaler C; Faizy T; Sedlacik J; Holst B; Stellmann JP; Young KL; Heesen C; Fiehler J; Siemonsen S
PLoS One; 2015; 10(12):e0144693. PubMed ID: 26659852
[TBL] [Abstract][Full Text] [Related]
30. 3D-Flair sequence at 3T in cochlear otosclerosis.
Lombardo F; De Cori S; Aghakhanyan G; Montanaro D; De Marchi D; Frijia F; Fortunato S; Forli F; Chiappino D; Berrettini S; Canapicchi R
Eur Radiol; 2016 Oct; 26(10):3744-51. PubMed ID: 26747254
[TBL] [Abstract][Full Text] [Related]
31. Improving Detection of Multiple Sclerosis Lesions in the Posterior Fossa Using an Optimized 3D-FLAIR Sequence at 3T.
Lecler A; El Sanharawi I; El Methni J; Gout O; Koskas P; Savatovsky J
AJNR Am J Neuroradiol; 2019 Jul; 40(7):1170-1176. PubMed ID: 31248862
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.
Gramsch C; Nensa F; Kastrup O; Maderwald S; Deuschl C; Ringelstein A; Schelhorn J; Forsting M; Schlamann M
Acta Radiol; 2015 May; 56(5):622-7. PubMed ID: 24867222
[TBL] [Abstract][Full Text] [Related]
33. Multiparametric MRI Evaluation of Developmental Venous Anomalies in the Brain: Association with Signal Changes on FLAIR in Patients with Multiple Sclerosis.
Sagtas E; Guneyli S; Akyilmaz DA; Yavas HG; Cakmak P; Ufuk F
Curr Med Imaging; 2020; 16(7):928-935. PubMed ID: 32416698
[TBL] [Abstract][Full Text] [Related]
34. Pitfalls of 3D FLAIR brain imaging: a prospective comparison with 2D FLAIR.
Kakeda S; Korogi Y; Hiai Y; Ohnari N; Sato T; Hirai T
Acad Radiol; 2012 Oct; 19(10):1225-32. PubMed ID: 22818791
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Unenhanced and Gadolinium-Enhanced Imaging in Multiple Sclerosis: Is Contrast Needed for Routine Follow-Up MRI?
Sadigh G; Saindane AM; Waldman AD; Lava NS; Hu R
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1476-1480. PubMed ID: 31439627
[TBL] [Abstract][Full Text] [Related]
36. Early contrast-enhanced magnetic resonance imaging with fluid-attenuated inversion recovery in multiple sclerosis.
Kataoka H; Taoka T; Ueno S
J Neuroimaging; 2009 Jul; 19(3):246-9. PubMed ID: 19021828
[TBL] [Abstract][Full Text] [Related]
37. Optimal sequences and sequence parameters for GBCA-enhanced MRI of the glymphatic system: a systematic literature review.
Mijnders LS; Steup FW; Lindhout M; van der Kleij PA; Brink WM; van der Molen AJ
Acta Radiol; 2021 Oct; 62(10):1324-1332. PubMed ID: 33153270
[TBL] [Abstract][Full Text] [Related]
38. 3D FLAIRED: 3D fluid attenuated inversion recovery for enhanced detection of lesions in multiple sclerosis.
Polak P; Magnano C; Zivadinov R; Poloni G
Magn Reson Med; 2012 Sep; 68(3):874-81. PubMed ID: 22139997
[TBL] [Abstract][Full Text] [Related]
39. Seven-Tesla Magnetization Transfer Imaging to Detect Multiple Sclerosis White Matter Lesions.
Chou IJ; Lim SY; Tanasescu R; Al-Radaideh A; Mougin OE; Tench CR; Whitehouse WP; Gowland PA; Constantinescu CS
J Neuroimaging; 2018 Mar; 28(2):183-190. PubMed ID: 28944575
[TBL] [Abstract][Full Text] [Related]
40. 3D MRI in multiple sclerosis: a study of three sequences at 3 T.
Mills RJ; Young CA; Smith ET
Br J Radiol; 2007 May; 80(953):307-20. PubMed ID: 17005516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
